Erratum: HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (Radiotherapy and Oncology (2014) 113 (317-323))

Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Roedel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Moennich D, Zips D, Von Neubeck C, Baretton GB, Loeck S, Thames HD, Krause M, Baumann M (2015)

Publication Type: Journal article, Erratum

Publication year: 2015

Journal

Radiotherapy and Oncology Elsevier

Book Volume: 114

Pages Range: 419-

Journal Issue: 3

DOI: 10.1016/j.radonc.2015.03.010

Involved external institutions

Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE) Technische Universität Dresden DE Germany (DE) Goethe-Universität Frankfurt am Main DE Germany (DE) University of Texas MD Anderson Cancer Center US United States (USA) (US)

How to cite

APA:

Lohaus, F., Linge, A., Tinhofer, I., Budach, V., Gkika, E., Stuschke, M.,... Baumann, M. (2015). Erratum: HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (Radiotherapy and Oncology (2014) 113 (317-323)). Radiotherapy and Oncology, 114(3), 419-. https://doi.org/10.1016/j.radonc.2015.03.010

MLA:

Lohaus, Fabian, et al. "Erratum: HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (Radiotherapy and Oncology (2014) 113 (317-323))." Radiotherapy and Oncology 114.3 (2015): 419-.

BibTeX: Download